Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. - Wikidata - awgldk - TriplyDB

Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection.

Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection.

http://www.wikidata.org/entity/Q34127272

about

Landmark trials affecting the surgical management of invasive breast cancer Recent progress in the treatment and prevention of cancer-related lymphedema Mapping lymph nodes in cancer management - role of (99m)Tc-tilmanocept injection Sentinel lymph node biopsy compared with axillary lymph node dissection in early breast cancer: a meta-analysis.Treatment related impairments in arm and shoulder in patients with breast cancer: a systematic review.Complication rates in patients with negative axillary nodes 10 years after local breast radiotherapy after either sentinel lymph node dissection or axillary clearance.Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08).A simple model to assess the probability of invasion in ductal carcinoma in situ of the breast diagnosed by needle biopsy.Relationship between arm morbidity and patient-reported outcomes following surgery in women with node-negative breast cancer: NSABP protocol B-32.Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32.Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial Sentinel node biopsy for breast cancer patients: issues for discussion and our practice.ER-poor and HER2-positive: a potential subtype of breast cancer to avoid axillary dissection in node positive patients after neoadjuvant chemo-trastuzumab therapy.Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial Axillary recurrences following positive sentinel lymph node biopsy with individual tumor cells or micrometastases and no axillary dissection.Axillary reverse mapping: five-year experience.The role of MRI in axillary lymph node imaging in breast cancer patients: a systematic review.Diagnostic accuracy of sentinel node identification is maintained with the addition of local lidocaine and subareolar radioactive colloid injection.Review of breast conservation therapy: then and now Sentinel Lymph Node Detection Using Carbon Nanoparticles in Patients with Early Breast Cancer The clinical manifestations and treatment of male breast cancer: a report of three cases.Contrast-Enhanced Color Doppler Ultrasonography for Preoperative Evaluation of Sentinel Lymph Node in Breast Cancer Patients.A nomogram to predict the probability of axillary lymph node metastasis in early breast cancer patients with positive axillary ultrasound.Comparison of relative versus absolute arm size change as criteria for quantifying breast cancer-related lymphedema: the flaws in current studies and need for universal methodology.A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance Screening for breast cancer-related lymphedema: the need for standardization Axillary radiotherapy: an alternative treatment option for adjuvant axillary management of breast cancer.Lymphedema following treatment for breast cancer: a new approach to an old problem.Long-term effects of complex decongestive therapy in breast cancer patients with arm lymphedema after axillary dissection.Sparing sentinel node biopsy through axillary lymph node fine needle aspiration in primary breast cancers.Breast and gynecologic cancer-related extremity lymphedema: a review of diagnostic modalities and management options.Impact of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial on clinical management of the axilla in older breast cancer patients: a SEER-medicare analysis.Morbidity after conventional dissection of axillary lymph nodes in breast cancer patients.Sentinel lymph node biopsy in primary breast cancer: window to management of the axilla.Breast-cancer related lymphedema: a review of procedure-specific incidence rates, clinical assessment AIDS, treatment paradigms, and risk reduction.Accelerated partial breast irradiation for early-stage breast cancer: controversies and current indications for use.Is DCIS breast cancer, and how do I treat it?Blue dye is sufficient for sentinel lymph node biopsy in breast cancer.Shoulder and arm morbidity in sentinel node-negative breast cancer patients: a systematic review.Incidence of and risk factors for sentinel lymph node metastasis in patients with a postoperative diagnosis of ductal carcinoma in situ.

P2860

Q26830129-E4C3C75E-4D36-47B0-B905-97DEBB80BB80 Q27009895-73866996-DA8F-472A-A49B-DEFB8BFC9754 Q27022042-6DE8D562-5699-4BBE-99C0-000589B5C51E Q31022615-72A7C330-CC4E-4150-B31D-FC584D20814E Q33590486-B165D1F4-9B05-499F-A17E-FF3177182D49 Q33783188-C76FAB5D-9176-40CC-9737-3D706889990B Q33862578-4ED6053C-826C-4F42-9A00-F60A0717FB87 Q33992894-ED207059-3AEB-482E-8A99-988D6A0949E1 Q34039923-26084BB2-2FC3-485C-AA5C-F9E6C81D6975 Q34131757-5566463E-E9A3-4B51-A6E1-14298428F434 Q34139672-29BCC5EB-2E57-4B0D-A175-A1B66A7B18E6 Q34479099-523EB9F1-E00D-4DB2-B04E-3C33D6F11B56 Q34680978-ABE9550E-3D1F-4B25-99E2-00EFB6819C0E Q34919537-05796AA9-8E58-4A3D-A35C-F91048BD1293 Q35125432-5E2B8B80-14BB-4D5E-8A0E-5311D8B6CDB1 Q35163199-CDF98399-E4FB-4054-BCEA-BDAAD36BB87E Q35225111-64D92EE0-C0C7-4D4D-8FDC-9EBF6EE515AD Q35300133-C3225AE8-BA1B-4A5B-ACD9-10EE2BBB2883 Q35433289-E1E6F426-DD4C-43A3-A32D-116E93321D03 Q35752488-14FDDBA0-ACE4-4690-99DB-52AD1AD84B85 Q36123350-9F10BCD4-1368-4B22-9897-A2B40F66478B Q36368153-086B2AA6-01A1-4423-BBBC-DAAF3615BCA5 Q36579394-FCC7996C-0904-4ACF-A5D9-41ECB5E7938D Q36587170-B1FE67EA-9AD0-4B34-8A3D-5C5623551904 Q36757710-BDB79F3A-9E09-4732-8EF2-8C3B6DDB38E8 Q36804470-DC936C57-3ADF-4B51-9164-B03308037197 Q36925117-B211272E-8107-49BD-B32D-8368ED7AC461 Q37200954-2455A09E-9D4B-49BC-98BF-34ADB9580052 Q37303487-C754919A-1479-4939-A265-4F87B47202AD Q37348043-C08982BD-BCBA-4689-A196-A3F5B071855C Q37366477-F8877103-2B29-453D-A862-F9383D25B140 Q37417172-EE7FA242-AA7D-48DC-A646-570D29178BC1 Q37702991-4EA7574A-A175-4336-A93F-DF0CA000358C Q38007324-A52820F8-3043-4188-9CE1-ADF7C152862A Q38023590-84825FEC-CF83-4961-94BD-21232CF2AE6B Q38062411-5D0E307E-25B6-4776-9580-54AEAC64C521 Q38067318-711C13A8-6149-4230-A91F-C304745EDAC3 Q38184924-9B6EC2D7-5413-48E5-B9A3-137E1DFBC087 Q38185305-86A6DE44-5666-4856-B2B2-E6B6A4F77A71 Q38393043-9CAC79A4-66B8-422B-BF75-E37089C81B39

P2860

Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection.

http://www.wikidata.org/entity/Q34127272

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Morbidity results from the NSA ...... on versus axillary dissection.

@ast

Morbidity results from the NSA ...... on versus axillary dissection.

@en

Morbidity results from the NSA ...... on versus axillary dissection.

@nl

type

label

Morbidity results from the NSA ...... on versus axillary dissection.

@ast

Morbidity results from the NSA ...... on versus axillary dissection.

@en

Morbidity results from the NSA ...... on versus axillary dissection.

@nl

prefLabel

Morbidity results from the NSA ...... on versus axillary dissection.

@ast

Morbidity results from the NSA ...... on versus axillary dissection.

@en

Morbidity results from the NSA ...... on versus axillary dissection.

@nl

P1433

Q34127272-7448C4A7-8445-438D-A949-75B01735F03A

P1476

Q34127272-B29416A2-C5B8-457E-8342-B964AAA06A29

P2093

Q34127272-50119170-794E-4D8A-AB45-255AA3F35AF7

Q34127272-5B47259F-8098-42A8-93B9-3CEDF6929484

Q34127272-62C272E1-E078-47E4-AB03-77B87E537F77

Q34127272-721770B4-2BDC-4866-8176-4F7B9CFDD5DD

Q34127272-B26E910F-0E91-4DE9-AF38-327CD0B89CBD

Q34127272-C8C2EF6E-E24D-4EDD-9247-E82711E62BFC

Q34127272-DAA7B07F-6426-407D-BDB1-7303C25A32FE

Q34127272-DDB80CC2-7B7F-4627-802A-BCA6C557F173

Q34127272-E3DE6B43-99FB-4923-BDAE-53D9247F7804

Q34127272-F7258473-175E-4352-B23F-DD2B59BE4469

P2860

Q34127272-14D9A79C-9B94-4447-A3B8-3C8304621C87

Q34127272-17391865-A6E8-42DD-AE01-9F738F016DB3

Q34127272-66DB27A3-A2E2-4F0F-A032-904D0AFCD4A1

Q34127272-8C21A8CE-B075-4192-9772-884A8B50ACFB

Q34127272-91CE0913-1C08-4456-BD74-C7826BEE58E4

Q34127272-D7F1922A-B978-4D9F-9F27-68E2FDB09B6B

Q34127272-E658BA06-78C8-44B7-B8FE-87DE1B9B0C3B

Q34127272-F6F7701C-4988-4E4C-B051-719B3378A4BE

P304

Q34127272-F3D618F1-B354-4AF7-A3CB-F57372C5DC56

P31

Q34127272-82E70BFA-EF55-41DF-81C5-D6696F180EF6

P356

Q34127272-C2931F00-5514-4BA6-8B9A-14707F3D958F

P433

Q34127272-A31A7D3C-D50C-4671-8F11-91044ACF2EF0

P478

Q34127272-C023249A-9077-450A-AFC8-645770712854

P50

Q34127272-5E0D772C-3D65-41C0-9168-ED47FAC1B9BE

P577

Q34127272-4B7C9F94-4024-4123-B483-5ADA383534C1

P5875

Q34127272-80EF478F-BC6F-457F-99C8-285648B2CC38

P698

Q34127272-07380986-0EA3-41A4-B319-5A5CBA3BAAB8

P921

Q34127272-E1A95868-6968-40A3-8164-D8367CD3FAC8

P932

Q34127272-7D13223B-8297-44E4-A55F-8A35CC91DE93

P356

P1433

Journal of Surgical Oncology

P1476

Morbidity results from the NSA ...... ion versus axillary dissection

@en

P2093

Ann M Brown

http://www.w3.org/2001/XMLSchema#string

David N Krag

http://www.w3.org/2001/XMLSchema#string

Donald L Weaver

http://www.w3.org/2001/XMLSchema#string

Eleftherios P Mamounas

http://www.w3.org/2001/XMLSchema#string

Joan M Skelly

http://www.w3.org/2001/XMLSchema#string

Joseph P Costantino

http://www.w3.org/2001/XMLSchema#string

National Surgical Adjuvant Breast, Bowel Project

http://www.w3.org/2001/XMLSchema#string

Norman Wolmark

http://www.w3.org/2001/XMLSchema#string

Seth P Harlow

http://www.w3.org/2001/XMLSchema#string

Stephanie R Land

http://www.w3.org/2001/XMLSchema#string

P2860

The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors.

Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial.

Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial.

Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial.

Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial.

Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial

Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer

A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast Cancer

P304

111-118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JSO.21535

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

Stewart Anderson

P577

2010-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45279657

http://www.w3.org/2001/XMLSchema#string

P698

20648579

http://www.w3.org/2001/XMLSchema#string

P921

P932

3072246

http://www.w3.org/2001/XMLSchema#string